Yunlei Hou

969 total citations
64 papers, 734 citations indexed

About

Yunlei Hou is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Yunlei Hou has authored 64 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Yunlei Hou's work include Synthesis and biological activity (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Protein Degradation and Inhibitors (7 papers). Yunlei Hou is often cited by papers focused on Synthesis and biological activity (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Protein Degradation and Inhibitors (7 papers). Yunlei Hou collaborates with scholars based in China, United Kingdom and Switzerland. Yunlei Hou's co-authors include Yanfang Zhao, Ping Gong, Mingze Qin, Yajing Liu, Ye Tian, Shaowei Chen, Chunyang Liu, Jia Jiang, Xia Wu and Siyu Fu and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and RSC Advances.

In The Last Decade

Yunlei Hou

59 papers receiving 718 citations

Peers

Countries citing papers authored by Yunlei Hou

Since Specialization

Citations

This map shows the geographic impact of Yunlei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunlei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunlei Hou more than expected).

Fields of papers citing papers by Yunlei Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunlei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunlei Hou. The network helps show where Yunlei Hou may publish in the future.

Co-authorship network of co-authors of Yunlei Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yunlei Hou. A scholar is included among the top collaborators of Yunlei Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunlei Hou. Yunlei Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment 2025 ·European Journal of Medicinal Chemistry ·Yunlei Hou, Shuang Li, (unknown), Long Zhang, Na Zhang, (unknown), Qi Huang, Zhiwei Li, (unknown), Zhiguo Xi, Minghui Tong, Ping Gong, Yanfang Zhao, Yajing Liu, Jiuyu Liu	1
2	Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment 2025 ·Journal of Medicinal Chemistry ·Wei Deng, Xuejian Wang, (unknown), Xiangjie Zhang, Yunlei Hou, Mingze Qin	0
3	Design, synthesis, and biological evaluation of 2,4-diaminopyrimidine inhibitors of hematopoietic progenitor kinase 1 2025 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Senxiang Yan, Yu Wang, Siyu Fu, (unknown), Yue Hao, (unknown), Minghui Tong, (unknown), Han Wang, Dong Zhao, (unknown), (unknown), Yanfang Zhao, Yunlei Hou	0
4	Small-molecule FGFR-targeted medicinal chemistry: Advances since 2020 and future perspectives 2025 ·European Journal of Medicinal Chemistry ·Yue Hao, Yu Wang, Na Zhang, (unknown), (unknown), Yu Bao, Yunlei Hou, Yanfang Zhao	0
5	Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease 2024 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xiaoqian Wang, (unknown), Xiao Chen, Dong Zhao, Yue Qiu, (unknown), Jiaqi Wang, (unknown), Na Zhang, Shuang Li, Ping Gong, Yunlei Hou	20
6	Novel biaryloxazolidinone derivatives with broad-spectrum antibacterial activity, favorable drug-like profiles and in vivo efficacy against linezolid-resistant Staphylococcus aureus 2024 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xinyu Huang, Lei Sun, (unknown), Zechen Wang, Hao Yue, Kun Wang, Yinliang Qi, Shan Peng, Xuan Shi, Zhiguo Xi, (unknown), (unknown), Yunlei Hou, Yanfang Zhao	4
7	Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management 2024 ·Bioorganic Chemistry ·Xiaoquan Yu, (unknown), (unknown), (unknown), (unknown), (unknown), Haoyu Xu, (unknown), Xiao Chen, Dong Zhao, Yue Qiu, Yunlei Hou	6
8	Identification of novel PD-1/PD-L1 small molecule inhibitors: virtual screening, synthesis and in vitro characterisation 2024 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Tingting Wu, Cheng Hu, (unknown), Zhongyuan Wang, Weiwei Ouyang, (unknown), Yunlei Hou, Dongsheng Zhao, (unknown), (unknown)	3
9	2-Aminopyrimidine derivatives as selective dual inhibitors of JAK2 and FLT3 for the treatment of acute myeloid leukemia 2023 ·Bioorganic Chemistry ·(unknown), (unknown), Jie Meng, (unknown), (unknown), Chen Wang, Yu‐Cheng Gu, H. Liang, (unknown), Minghui Tong, Xuan Shi, Yunlei Hou, Yajing Liu, Yanfang Zhao	5
10	Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease 2023 ·Bioorganic Chemistry ·Ningwei Wang, Wenlong Jia, Junqin Wang, (unknown), Yaoyang Liu, Dehua Huang, Xiaohan Mei, Xinxin Xiong, (unknown), Yadong Tang, Guang Chen, Donghua Di, Yunlei Hou, Yajing Liu	11
11	Overview of CFTR activators and their recent studies for dry eye disease: a review 2023 ·RSC Medicinal Chemistry ·Jie Wu, Xiaoqian Wang, Yanfang Zhao, Yunlei Hou, Ping Gong	2
12	Structure-based drug design, synthesis, and biological evaluation of novel 1,3,5-triazine or pyrimidine derivatives containing benzoyl hydrazine moiety as PI3Kα selective inhibitors 2023 ·Bioorganic Chemistry ·Siyu Fu, Jiuyu Liu, (unknown), (unknown), Yue Hao, (unknown), Kang Wang, (unknown), Yunlei Hou, Yanfang Zhao	4
13	Design, synthesis, and antibacterial evaluation of a novel series of biaryloxazolidinone derivatives against Gram-positive bacteria 2022 ·New Journal of Chemistry ·Yinliang Qi, (unknown), Kun Wang, (unknown), (unknown), (unknown), Mingfei Xiao, (unknown), Siyu Liu, Yunlei Hou, Yanfang Zhao	3
14	Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction 2021 ·Journal of Medicinal Chemistry ·Mingze Qin, Yangyang Meng, (unknown), Lei Liu, Haotian Zhang, Simeng Wang, Chunyang Liu, Xia Wu, Di Wu, Ye Tian, Yunlei Hou, Yanfang Zhao, Yajing Liu, Congjun Xu, Lihui Wang	46
15	Insights into non-peptide small-molecule inhibitors of the PD-1/PD-L1 interaction: Development and perspective 2021 ·Bioorganic & Medicinal Chemistry ·Xia Wu, Yangyang Meng, Lei Liu, Guowei Gong, Haotian Zhang, Yunlei Hou, Chunyang Liu, Di Wu, Mingze Qin	14
16	Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity 2020 ·Bioorganic & Medicinal Chemistry ·Mingze Qin, Ye Tian, (unknown), Qi Cao, (unknown), Chunyang Liu, Xia Wu, Lei Liu, Yangyang Meng, Xiaobo Wang, Haotian Zhang, Yunlei Hou	8
17	Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Yang Wang, (unknown), Yunlei Hou, Yajing Liu, Shi Ding, Ye Chen	42
18	Design, synthesis and biological evaluation of novel pteridinone derivatives possessing a hydrazone moiety as potent PLK1 inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·Zhiwei Li, Le Xu, (unknown), Yanfang Zhao, Tao Hu, (unknown), Yajing Liu, Yunlei Hou	9
19	Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety 2020 ·Bioorganic & Medicinal Chemistry Letters ·Jia Jiang, Yunlei Hou, (unknown), (unknown), (unknown), (unknown), Yanfang Zhao	26
20	Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors 2016 ·European Journal of Medicinal Chemistry ·Mingmei Liu, Yunlei Hou, (unknown), (unknown), Qian Ping, Zhuang Guo, Liying Xu, (unknown)	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact